Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans.

Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans.

<h4>Background</h4>Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme inhibitors (ACEIs) may positively or negatively impact outcomes in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We investigated the association of ARB or ACEI use with...

Full description

Bibliographic Details
Main Authors: Catherine G Derington, Jordana B Cohen, April F Mohanty, Tom H Greene, James Cook, Jian Ying, Guo Wei, Jennifer S Herrick, Vanessa W Stevens, Barbara E Jones, Libo Wang, Alexander R Zheutlin, Andrew M South, Thomas C Hanff, Steven M Smith, Rhonda M Cooper-DeHoff, Jordan B King, G Caleb Alexander, Dan R Berlowitz, Faraz S Ahmad, M Jason Penrod, Rachel Hess, Molly B Conroy, James C Fang, Michael A Rubin, Srinivasan Beddhu, Alfred K Cheung, Weiming Xian, William S Weintraub, Adam P Bress
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0248080

Internet

https://doi.org/10.1371/journal.pone.0248080

Similar Items